Cancer Commons is a nonprofit network of patients, physicians, and scientists from many disciplines. We identify the knowledge needed to get the best possible outcomes and continuously refine it based on clinical results and breaking research. Specifically, we focus on providing expert, compassionate, one-on-one guidance to patients and families struggling with cancer of any type or stage.
We foster a network of leading physicians, molecular tumor boards, cancer researchers, and computer scientists to leverage one another’s expertise and resources, and empower the global community to share data and knowledge. We provide relevant knowledge from top experts and from similar patients so that patients and their caretakers can make better, more informed treatment decisions. We continuously validate and refine the world’s collective cancer knowledge, based on patients’ clinical results and the latest research.
Why we’re unique.
In the era of molecular medicine, advanced cancers are characterized by thousands of genetic alterations, potentially creating tens of thousands of clinically distinct subtypes. Moreover, there are hundreds of approved therapies, which have never been tested head to head, or in combinations. Conventional clinical trials cannot efficiently search this huge combinatorial space.
In the absence of definitive clinical studies, the best way to help current patients is by aggregating and validating the insights, intuitions, and experiences of our best clinicians. By capturing the unique experiences of patients being treated at top centers with investigational drugs and cocktails, Cancer Commons will enable the whole cancer community to learn, much more efficiently than traditional clinical trials, the best way to treat similar patients wherever they are seen. Given the wide variation in cancer treatment and outcomes across institutions, we are convinced that our efforts to learn from the best and get that knowledge to the right patients and physicians at the right time will save innumerable lives, even without new blockbuster drugs.
Only a patient-centric non-profit like Cancer Commons, committed to connecting and leveraging everyone touched by cancer, could hope to overcome the widespread aversion to data sharing and collaboration that pervades the medical establishment.